Technology Wanted

New medicines in the area of psychiatry

As a large multinational corporation operating in the healthcare sector, we are looking for certain new technologies to license or acquire.


Our goal is to be a leader in neuroscience research delivering a range of life-changing medicines in key areas of unmet medical need. We are making great research efforts in diseases related to the central nervous system (CNS).

Our research in this field is focused on neurological diseases, psychiatric disorders, and pain and anaesthesia.

Areas of Interest<p> </p>



- Novel therapeutics targeting psychosis with clinical proof of concept

- Novel therapeutics targeting cognition

- 3rd generation anti-psychotic


- MT-1 agonist (phase II/III)

- Triple re-uptake inhibitor (serotonin / norepinephrine / dopamine)

- 1st generation CRF-1 antagonist (phase II/III)

- Novel diagnostic tools

- Novel biomarkers and genetic markers

- Novel ligands for in-vivo occupancy and PET imaging

Patents and Intellectual Property

We will only consider technology covered by a patent.